In Vitro Diagnostics (IVD) include reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. The reagents, instruments and systems are intended for use in the collection, preparation, and examination of specimens taken from the human body. The categories tracked under this market are Cardiac Disease, Hematological Disorders, Hormonal Disorders, Metabolic Disorder, Infectious Disease, IVD Analyzers and Reagents, Oncology and Reproductive Health Diagnostics. Hepatitis B Test Kits are used for the detection of Hepatitis B virus (HBV), a hepadnavirus that causes acute and chronic liver inflammation. GlobalData uses proprietary data and analytics to provide a comprehensive report on the hepatitis b tests devices market, including market shares of different players within South Korea. Buy the latest report here.
In 2022, GlobalData’s Market Model methodology determined that the leading player in the hepatitis b tests market in South Korea was F. Hoffmann-La Roche followed by Siemens, Abbott Laboratories, Hologic, bioMerieux, Quidelortho, DiaSorin and Bio-Rad Laboratories.
The Hepatitis B Test Kits sub-segment comprises Hepatitis B Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) Tests and Hepatitis B Nucleic Acid Amplification Tests (NAATs)
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the hepatitis b tests devices market within South Korea was expected to be over $20m in 2022.
For the latest complete market share analysis of hepatitis b tests device market in South Korea, buy the report here.